Alpha Teknova (NASDAQ:TKNO) Releases Quarterly Earnings Results

by · The Cerbat Gem

Alpha Teknova (NASDAQ:TKNO – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.08) earnings per share for the quarter, Zacks reports. Alpha Teknova had a negative net margin of 55.24% and a negative return on equity of 26.51%. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Stock Performance

NASDAQ:TKNO traded down $0.14 during trading hours on Thursday, hitting $4.81. 354,600 shares of the company were exchanged, compared to its average volume of 337,389. The stock has a market capitalization of $257.38 million, a price-to-earnings ratio of -11.45 and a beta of 0.39. Alpha Teknova has a 52-week low of $3.94 and a 52-week high of $10.37. The company has a debt-to-equity ratio of 0.17, a current ratio of 5.87 and a quick ratio of 4.70. The company’s 50 day moving average price is $5.08 and its 200-day moving average price is $5.30.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on TKNO. Weiss Ratings reissued a “sell (d-)” rating on shares of Alpha Teknova in a research report on Wednesday, October 8th. Stephens upgraded Alpha Teknova to a “strong-buy” rating and set a $8.00 price objective for the company in a report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Alpha Teknova has a consensus rating of “Moderate Buy” and an average target price of $10.00.

Read Our Latest Stock Report on Alpha Teknova

Institutional Investors Weigh In On Alpha Teknova

Large investors have recently made changes to their positions in the stock. Massar Capital Management LP increased its position in shares of Alpha Teknova by 185.7% in the 2nd quarter. Massar Capital Management LP now owns 200,000 shares of the company’s stock valued at $982,000 after acquiring an additional 130,000 shares during the period. Balyasny Asset Management L.P. grew its stake in Alpha Teknova by 19.5% during the 2nd quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company’s stock valued at $4,912,000 after purchasing an additional 163,526 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Alpha Teknova by 3.3% in the second quarter. Bank of America Corp DE now owns 229,429 shares of the company’s stock valued at $1,126,000 after purchasing an additional 7,256 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Alpha Teknova in the second quarter worth about $29,000. Finally, Marshall Wace LLP lifted its holdings in shares of Alpha Teknova by 83.0% during the second quarter. Marshall Wace LLP now owns 90,032 shares of the company’s stock worth $442,000 after purchasing an additional 40,825 shares during the period. 13.81% of the stock is owned by hedge funds and other institutional investors.

About Alpha Teknova

(Get Free Report)

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

Further Reading